Daily Pharmacy News

Get your free subscription started now. Just enter your email address below.

PNN JournalWatch — 11.28.22

New England Journal of Medicine: Climate Change and Vectorborne Diseases

Lancet: LY3437943, A Novel Triple GIP, GLP-1, and Glucagon Receptor Agonist in People With Type 2 Diabetes: A Phase 1b, Multicentre, Double-Blind, Placebo-Controlled, Randomised, Multiple-Ascending Dose Trial

Journal of Clinical Oncology: Electronic Nicotine Delivery Systems: An Updated Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology

Journal of Clinical Oncology: Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

Journal of Clinical Oncology: Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)

Medical Care: Naloxone Prescribing Associated With Reduced Emergency Department Visits in the Military Health System

Medical Care: Racial/Ethnic Disparities in Substance Use Treatment in Medicaid Managed Care in New York City—The Role of Plan and Geography

Source: Lancet, New England Journal of Medicine, Journal of Clinical Oncology, Medical Care